SMTL ID : 6ani.1

Coltuximab Fab in complex with anti-Kappa VHH domain

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain C: V.11, K.13, A.121 Chain E: N.63 4 PLIP interactions: 2 interactions with chain C, 2 interactions with chain E Hydrogen bonds: C:K.13, C:K.13, E:N.63, E:N.63 GOL.2: 6 residues within 4Å: Chain D: I.10, S.12, E.102, P.138, R.139, E.140 4 PLIP interactions: 4 interactions with chain D Hydrogen bonds: D:S.12, D:R.139 Water bridges: D:I.10, D:S.12

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ereno-Orbea, J. et al., Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments. J. Mol. Biol. (2018)

Release Date

2018-01-31

Peptides

Anti-Kappa VHH domain: AB
Coltuximab Fab heavy chain: CE
Coltuximab Fab light chain: DF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
K

C
H

E
I

D
L

F
M

Anti-Kappa VHH domain

Coltuximab Fab heavy chain

Coltuximab Fab light chain

Related Entries With Identical Sequence